![]() Aldeyra Therapeutics Aldeyra Therapeutics develops drug candidates for capturing and removing free aldehydes to treat and prevent diseases. | ![]() ROCAtest ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers. | ||
Founding Date | Founding Date 2004 | Founding Date 2010 | Founding Date 2007 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Lexington, US HQ | Locations Leeds, GB HQ Royston, GB Boston, US Memphis, US | Locations Cambridge, US HQ |
Employees | Employees 1958% increase | Employees 29 | Employees 324187% increase |
Valuation ($) | Valuation ($) 333.9 m | Valuation ($) N/A | Valuation ($) 359.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £568.3k (FY, 2015) | Revenue (est.) $236.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods £28.5k (FY, 2015) | Cost of goods $39.5m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit £539.7k (FY, 2015) | Gross profit $196.7m (FY, 2025) |
Net income | Net income ($33.8m) (FY, 2025) | Net income (£2.7m) (FY, 2015) | Net income ($5.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 7.8m | Total funding raised $ 17m | Total funding raised N/A |

ROCAtest (also known as Abcodia) is an innovative biotech company engaged in the validation and discovery of molecular biomarkers.
View company
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
View company